Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2006-08-01
2006-08-01
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C544S330000, C544S332000
Reexamination Certificate
active
07084148
ABSTRACT:
A compound of formula (I):and pharmaceutically acceptable derivatives thereof, wherein R1is H or C1-6alkyl; R2iswhereindefines the point of attachment of the ring; and R3is C1-6alkyl or NH2. Compounds of formula (I) are potent and selective inhibitors of COX-2 and are of use in the treatment of pain, fever, inflammation of a variety of conditions and diseases.
REFERENCES:
patent: 3149109 (1964-09-01), Neustaedter et al.
patent: 3592895 (1971-07-01), Hepworth et al.
patent: 5474995 (1995-12-01), Ducharme et al.
patent: 5760068 (1998-06-01), Talley et al.
patent: 5972986 (1999-10-01), Seibert et al.
patent: 6153619 (2000-11-01), Wood et al.
patent: 6306866 (2001-10-01), Wood et al.
patent: 6313072 (2001-11-01), Scheiblich et al.
patent: 6780869 (2004-08-01), Green et al.
patent: 6780870 (2004-08-01), Carter et al.
patent: 2003/0013717 (2003-01-01), Mangel et al.
patent: 19909541 (1999-03-01), None
patent: 9241161 (1997-09-01), None
patent: WO 9607641 (1996-03-01), None
patent: WO 96 24585 (1996-08-01), None
patent: WO 96 41625 (1996-12-01), None
patent: WO 96 41645 (1996-12-01), None
patent: WO 98/03484 (1998-01-01), None
patent: WO 98 16227 (1998-04-01), None
patent: WO 98/24782 (1998-06-01), None
patent: WO 99 01439 (1999-01-01), None
patent: WO 01/38311 (2001-05-01), None
patent: WO 01/58881 (2001-08-01), None
patent: WO 02/18374 (2002-03-01), None
patent: WO 02/096427 (2002-12-01), None
patent: WO 02/096885 (2002-12-01), None
patent: WO 02/096886 (2002-12-01), None
Naesdal et al., PubMed Abstract (Eur J Gastroenterol Hepatol 13(12):1401-6), Dec. 2001.
Simone, JV., et al. Oncology: Introduction, Cecil Textbook of Medicine, 20thEdition, vol. 1, pp. 1004-1010, 1996.
Layzer, R.B., et al. Degenerative Diseases of the Nervous System, Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 2050-2057, 1996.
Damasio, A.R., et al. Alzheimer's Disease and Related Dementias, Cecil Textbook of Medicine, vol. 2, pp. 1992-1996, 1996.
Freston, J.W., et al. Rationalizing Cyclooxygenase (COX) Inhibition for Maximal Efficacy and Minimal Adverse Events + Abstract, Am. J. Med. 107(6A):78S-88S; Discussion 89S), Dec. 1999.
Naesdal, J. et al. “Gastro-Duodenal Protection in an Era of Cyclo-Oxygenase-2-Selective Nonsteroidal Anti-inflammatory Drugs.” PubMed Abstract, Eur J Gastroenterol Hepatol. 13(12):1401-1406, Dec. 2001.
Douglas, R.G., Jr. Introduction to Viral Diseases: Cecil Textbook of Medicine, 20thEdition, vol. 2, pp. 1739-1747, 1996.
Carter Malcolm Clive
Naylor Alan
Pass Martin
Payne Jeremy John
Pegg Neil Anthony
Rao Deepak
SmithKline Beecham Corporation
Young J. Scott
LandOfFree
Substituted pyrimidines as selective cyclooxygenase-2... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted pyrimidines as selective cyclooxygenase-2..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted pyrimidines as selective cyclooxygenase-2... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3715619